This research report focuses on the Pharma 4.0 Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Pharma 4.0 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Cloud
- 1.2.3 On-premise
- 1.3 Market by Application
- 1.3.1 Global Pharma 4.0 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Pharmaceutical Industry
- 1.3.3 IoT Industry
- 1.3.4 Medical Equipment Industry
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Pharma 4.0 Market Perspective (2017-2028)
- 2.2 Pharma 4.0 Growth Trends by Region
- 2.2.1 Pharma 4.0 Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Pharma 4.0 Historic Market Size by Region (2017-2022)
- 2.2.3 Pharma 4.0 Forecasted Market Size by Region (2023-2028)
- 2.3 Pharma 4.0 Market Dynamics
- 2.3.1 Pharma 4.0 Industry Trends
- 2.3.2 Pharma 4.0 Market Drivers
- 2.3.3 Pharma 4.0 Market Challenges
- 2.3.4 Pharma 4.0 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Pharma 4.0 Players by Revenue
- 3.1.1 Global Top Pharma 4.0 Players by Revenue (2017-2022)
- 3.1.2 Global Pharma 4.0 Revenue Market Share by Players (2017-2022)
- 3.2 Global Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Pharma 4.0 Revenue
- 3.4 Global Pharma 4.0 Market Concentration Ratio
- 3.4.1 Global Pharma 4.0 Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Pharma 4.0 Revenue in 2021
- 3.5 Pharma 4.0 Key Players Head office and Area Served
- 3.6 Key Players Pharma 4.0 Product Solution and Service
- 3.7 Date of Enter into Pharma 4.0 Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma 4.0 Breakdown Data by Type
- 4.1 Global Pharma 4.0 Historic Market Size by Type (2017-2022)
- 4.2 Global Pharma 4.0 Forecasted Market Size by Type (2023-2028)
5 Pharma 4.0 Breakdown Data by Application
- 5.1 Global Pharma 4.0 Historic Market Size by Application (2017-2022)
- 5.2 Global Pharma 4.0 Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Pharma 4.0 Market Size (2017-2028)
- 6.2 North America Pharma 4.0 Market Size by Type
- 6.2.1 North America Pharma 4.0 Market Size by Type (2017-2022)
- 6.2.2 North America Pharma 4.0 Market Size by Type (2023-2028)
- 6.2.3 North America Pharma 4.0 Market Share by Type (2017-2028)
- 6.3 North America Pharma 4.0 Market Size by Application
- 6.3.1 North America Pharma 4.0 Market Size by Application (2017-2022)
- 6.3.2 North America Pharma 4.0 Market Size by Application (2023-2028)
- 6.3.3 North America Pharma 4.0 Market Share by Application (2017-2028)
- 6.4 North America Pharma 4.0 Market Size by Country
- 6.4.1 North America Pharma 4.0 Market Size by Country (2017-2022)
- 6.4.2 North America Pharma 4.0 Market Size by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Pharma 4.0 Market Size (2017-2028)
- 7.2 Europe Pharma 4.0 Market Size by Type
- 7.2.1 Europe Pharma 4.0 Market Size by Type (2017-2022)
- 7.2.2 Europe Pharma 4.0 Market Size by Type (2023-2028)
- 7.2.3 Europe Pharma 4.0 Market Share by Type (2017-2028)
- 7.3 Europe Pharma 4.0 Market Size by Application
- 7.3.1 Europe Pharma 4.0 Market Size by Application (2017-2022)
- 7.3.2 Europe Pharma 4.0 Market Size by Application (2023-2028)
- 7.3.3 Europe Pharma 4.0 Market Share by Application (2017-2028)
- 7.4 Europe Pharma 4.0 Market Size by Country
- 7.4.1 Europe Pharma 4.0 Market Size by Country (2017-2022)
- 7.4.2 Europe Pharma 4.0 Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Pharma 4.0 Market Size (2017-2028)
- 8.2 Asia-Pacific Pharma 4.0 Market Size by Type
- 8.2.1 Asia-Pacific Pharma 4.0 Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Pharma 4.0 Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Pharma 4.0 Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Pharma 4.0 Market Size by Application
- 8.3.1 Asia-Pacific Pharma 4.0 Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Pharma 4.0 Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Pharma 4.0 Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Pharma 4.0 Market Size by Region
- 8.4.1 Asia-Pacific Pharma 4.0 Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Pharma 4.0 Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Pharma 4.0 Market Size (2017-2028)
- 9.2 Latin America Pharma 4.0 Market Size by Type
- 9.2.1 Latin America Pharma 4.0 Market Size by Type (2017-2022)
- 9.2.2 Latin America Pharma 4.0 Market Size by Type (2023-2028)
- 9.2.3 Latin America Pharma 4.0 Market Share by Type (2017-2028)
- 9.3 Latin America Pharma 4.0 Market Size by Application
- 9.3.1 Latin America Pharma 4.0 Market Size by Application (2017-2022)
- 9.3.2 Latin America Pharma 4.0 Market Size by Application (2023-2028)
- 9.3.3 Latin America Pharma 4.0 Market Share by Application (2017-2028)
- 9.4 Latin America Pharma 4.0 Market Size by Country
- 9.4.1 Latin America Pharma 4.0 Market Size by Country (2017-2022)
- 9.4.2 Latin America Pharma 4.0 Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Pharma 4.0 Market Size (2017-2028)
- 10.2 Middle East & Africa Pharma 4.0 Market Size by Type
- 10.2.1 Middle East & Africa Pharma 4.0 Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Pharma 4.0 Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Pharma 4.0 Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Pharma 4.0 Market Size by Application
- 10.3.1 Middle East & Africa Pharma 4.0 Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Pharma 4.0 Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Pharma 4.0 Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Pharma 4.0 Market Size by Country
- 10.4.1 Middle East & Africa Pharma 4.0 Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Pharma 4.0 Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Pfizer Inc
- 11.1.1 Pfizer Inc Company Details
- 11.1.2 Pfizer Inc Business Overview
- 11.1.3 Pfizer Inc Pharma 4.0 Introduction
- 11.1.4 Pfizer Inc Revenue in Pharma 4.0 Business (2017-2022)
- 11.1.5 Pfizer Inc Recent Developments
- 11.2 Abbott Laboratories
- 11.2.1 Abbott Laboratories Company Details
- 11.2.2 Abbott Laboratories Business Overview
- 11.2.3 Abbott Laboratories Pharma 4.0 Introduction
- 11.2.4 Abbott Laboratories Revenue in Pharma 4.0 Business (2017-2022)
- 11.2.5 Abbott Laboratories Recent Developments
- 11.3 GE Healthcare
- 11.3.1 GE Healthcare Company Details
- 11.3.2 GE Healthcare Business Overview
- 11.3.3 GE Healthcare Pharma 4.0 Introduction
- 11.3.4 GE Healthcare Revenue in Pharma 4.0 Business (2017-2022)
- 11.3.5 GE Healthcare Recent Developments
- 11.4 Boston Scientific
- 11.4.1 Boston Scientific Company Details
- 11.4.2 Boston Scientific Business Overview
- 11.4.3 Boston Scientific Pharma 4.0 Introduction
- 11.4.4 Boston Scientific Revenue in Pharma 4.0 Business (2017-2022)
- 11.4.5 Boston Scientific Recent Developments
- 11.5 Medtronic Plc.
- 11.5.1 Medtronic Plc. Company Details
- 11.5.2 Medtronic Plc. Business Overview
- 11.5.3 Medtronic Plc. Pharma 4.0 Introduction
- 11.5.4 Medtronic Plc. Revenue in Pharma 4.0 Business (2017-2022)
- 11.5.5 Medtronic Plc. Recent Developments
- 11.6 Lonza Group AG
- 11.6.1 Lonza Group AG Company Details
- 11.6.2 Lonza Group AG Business Overview
- 11.6.3 Lonza Group AG Pharma 4.0 Introduction
- 11.6.4 Lonza Group AG Revenue in Pharma 4.0 Business (2017-2022)
- 11.6.5 Lonza Group AG Recent Developments
- 11.7 GlaxoSmithKline plc.
- 11.7.1 GlaxoSmithKline plc. Company Details
- 11.7.2 GlaxoSmithKline plc. Business Overview
- 11.7.3 GlaxoSmithKline plc. Pharma 4.0 Introduction
- 11.7.4 GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2017-2022)
- 11.7.5 GlaxoSmithKline plc. Recent Developments
- 11.8 Koninklijke Philips N.V.
- 11.8.1 Koninklijke Philips N.V. Company Details
- 11.8.2 Koninklijke Philips N.V. Business Overview
- 11.8.3 Koninklijke Philips N.V. Pharma 4.0 Introduction
- 11.8.4 Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2017-2022)
- 11.8.5 Koninklijke Philips N.V. Recent Developments
- 11.9 Glatt GmbH
- 11.9.1 Glatt GmbH Company Details
- 11.9.2 Glatt GmbH Business Overview
- 11.9.3 Glatt GmbH Pharma 4.0 Introduction
- 11.9.4 Glatt GmbH Revenue in Pharma 4.0 Business (2017-2022)
- 11.9.5 Glatt GmbH Recent Developments
- 11.10 Vertex
- 11.10.1 Vertex Company Details
- 11.10.2 Vertex Business Overview
- 11.10.3 Vertex Pharma 4.0 Introduction
- 11.10.4 Vertex Revenue in Pharma 4.0 Business (2017-2022)
- 11.10.5 Vertex Recent Developments
- 11.11 Johnson & Johnson
- 11.11.1 Johnson & Johnson Company Details
- 11.11.2 Johnson & Johnson Business Overview
- 11.11.3 Johnson & Johnson Pharma 4.0 Introduction
- 11.11.4 Johnson & Johnson Revenue in Pharma 4.0 Business (2017-2022)
- 11.11.5 Johnson & Johnson Recent Developments
- 11.12 Goodly Innovations
- 11.12.1 Goodly Innovations Company Details
- 11.12.2 Goodly Innovations Business Overview
- 11.12.3 Goodly Innovations Pharma 4.0 Introduction
- 11.12.4 Goodly Innovations Revenue in Pharma 4.0 Business (2017-2022)
- 11.12.5 Goodly Innovations Recent Developments
- 11.13 QbDVision
- 11.13.1 QbDVision Company Details
- 11.13.2 QbDVision Business Overview
- 11.13.3 QbDVision Pharma 4.0 Introduction
- 11.13.4 QbDVision Revenue in Pharma 4.0 Business (2017-2022)
- 11.13.5 QbDVision Recent Developments
- 11.14 Electrosan
- 11.14.1 Electrosan Company Details
- 11.14.2 Electrosan Business Overview
- 11.14.3 Electrosan Pharma 4.0 Introduction
- 11.14.4 Electrosan Revenue in Pharma 4.0 Business (2017-2022)
- 11.14.5 Electrosan Recent Developments
- 11.15 GoSilico
- 11.15.1 GoSilico Company Details
- 11.15.2 GoSilico Business Overview
- 11.15.3 GoSilico Pharma 4.0 Introduction
- 11.15.4 GoSilico Revenue in Pharma 4.0 Business (2017-2022)
- 11.15.5 GoSilico Recent Developments
- 11.16 Smart Factory
- 11.16.1 Smart Factory Company Details
- 11.16.2 Smart Factory Business Overview
- 11.16.3 Smart Factory Pharma 4.0 Introduction
- 11.16.4 Smart Factory Revenue in Pharma 4.0 Business (2017-2022)
- 11.16.5 Smart Factory Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer